Publications of Institute of Radiopharmaceutical Cancer Research

147 Publications

2024

Deep learning based bilateral filtering for edge-preserving denoising of respiratory-gated PET

Maus, J.; Nikulin, P.; Hofheinz, F.; Petr, J.; Braune, A.; et al. (7 authors)


Value of [18F] FDG PET/CT parameters of the primary tumor in assessing overall survival in NSCLC patients with cN1-cN3 lymph nodes involvement

Cegla, P.; Hofheinz, F.; Czepczyński, R.; Witkowska, K.; van den Hoff, J.; et al. (8 authors)

  • Open Access Logo Reports of Practical Oncology and Radiotherapy 29(2024)1, 97-102
    DOI: 10.5603/rpor.99360

2023

Combination of tumor asphericity and an extracellular matrix-related prognostic gene signature in non-small cell lung cancer patients

Zschaeck, S.; Klinger, B.; van den Hoff, J.; Cegla, P.; Apostolova, I.; et al. (13 authors)


Asphericity derived from [18F]FDG PET as a new prognostic parameter in cervical cancer patients

Cegla, P.; Hofheinz, F.; Burchardt, E.; Czepczyński, R.; Kubiak, A.; et al. (10 authors)


18F-FDG PET/CT-derived total lesion glycolysis predicts abscess formation in patients with surgically confirmed infective endocarditis: Results of a retrospective study at a tertiary center

Maria Sag, S. J.; Menhart, K.; Hitzenbichler, F.; Schmid, C.; Hofheinz, F.; et al. (10 authors)


Radiomics predictive modeling from dual-time-point FDG PET Ki parametric maps: application to chemotherapy response in lymphoma

Samimi, R.; Shiri, I.; Ahmadyar, Y.; van den Hoff, J.; Kamali-Asl, A.; et al. (9 authors)


A convolutional neural network with self-attention for fully automated metabolic tumor volume delineation of head and neck cancer in [18F]FDG PET/CT

Nikulin, P.; Zschaeck, S.; Maus, J.; Cegla, P.; Lombardo, E.; et al. (20 authors)


2022

Development of a neurotensin-derived 68Ga-labeled PET ligand with high in vivo stability for imaging of NTS1 receptor-expressing tumors

Schindler, L.; Moosbauer, J.; Schmidt, D.; Spruss, T.; Grätz, L.; et al. (13 authors)


Correlation Between Quantitative PSMA PET Parameters and Clinical Risk Factors in Non-Metastatic Primary Prostate Cancer Patients

Zschaeck, S.; Andela, S. B.; Amthauer, H.; Furth, C.; Rogasch, J. M.; et al. (8 authors)


Comparison of Image Quality and Spatial Resolution Between 18F, 68Ga and 64Cu Phantom Measurements Using a Digital Biograph Vision PET/CT

Braune, A.; Oehme, L.; Freudenberg, R.; Hofheinz, F.; van den Hoff, J.; et al. (7 authors)


Influences on PET Quantification and Interpretation

Rogasch, J.; Hofheinz, F.; van Heek, L.; Voltin, C.; Boellaard, R.; et al. (6 authors)


2021

Prognostic Value of Pretherapeutic Primary Tumour MTV from [18F]FDG PET in Radically Treated Cervical Cancer Patients

Cegla, P.; Hofheinz, F.; CholewińSki, W.; Czepczynski, R.; Kubiak, A.; et al. (9 authors)


“Clickable” albumin binders for modulating the tumor uptake of targeted radiopharmaceuticals

Brandt, F.; Ullrich, M.; Laube, M.; Kopka, K.; Bachmann, M.; et al. (10 authors)


Final Results of the Prospective Biomarker Trial PETra: [11C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma

Seidlitz, A.; Beuthien-Baumann, B.; Löck, S.; Jentsch, C.; Platzek, I.; et al. (16 authors)


Overestimation of grey matter atrophy in glioblastoma patients following radio(chemo)therapy

Gommlich, A.; Raschke, F.; Petr, J.; Seidlitz, A.; Jentsch, C.; et al. (12 authors)

  • Open Access Logo Magnetic Resonance Materials in Physics, Biology and Medicine 35(2022), 145-152
    Online First (2021) DOI: 10.1007/s10334-021-00922-3

A convolutional neural network for fully automated blood SUV determination to facilitate SUR computation in oncological FDG-PET

Nikulin, P.; Hofheinz, F.; Maus, J.; Li, Y.; Bütof, R.; et al. (11 authors)

  • Open Access Logo European Journal of Nuclear Medicine and Molecular Imaging 48(2021), 995-1004
    Online First (2020) DOI: 10.1007/s00259-020-04991-9

2020

PET measured hypoxia and MRI parameters in re-irradiated head and neck squamous cell carcinomas: findings of a prospective pilot study

Rogasch, J.; Beck, M.; Stromberger, C.; Hofheinz, F.; Ghadjar, P.; et al. (12 authors)


KRAS mutation effects on the 2-[18F]FDG PET uptake of colorectal adenocarcinoma metastases in the liver

Popovic, M.; Talarico, O.; van den Hoff, J.; Kunin, H.; Zhang, Z.; et al. (11 authors)


Short-duration dynamic FDG PET imaging: Optimization and clinical application

Samimi, R.; Kamali-Asl, A.; Geramifar, P.; van den Hoff, J.; Rahmim, A.


Asphericity of tumor FDG uptake in non-small cell lung cancer: Reproducibility and implications for harmonization in multicenter studies

Rogasch, J.; Furth, C.; Bluemel, S.; Radojewski, P.; Amthauer, H.; et al. (6 authors)


A FDG-PET radiomics signature detects esophageal squamous cell carcinoma patients who do not benefit from chemoradiation

Li, Y.; Beck, M.; Päßler, T.; Lili, C.; Wu, H.; et al. (17 authors)


Prognostic value of baseline [18F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients

Zschaeck, S.; Li, Y.; Lin, Q.; Beck, M.; Amthauer, H.; et al. (16 authors)


Combined tumor plus nontumor interim FDG‐PET parameters are prognostic for response to chemoradiation in squamous cell esophageal cancer

Zschaeck, S.; Li, Y.; Bütof, R.; Lili, C.; Hua, W.; et al. (15 authors)


Reconstructed spatial resolution and contrast recovery with Bayesian penalized likelihood reconstruction (Q.Clear) for FDG-PET compared to time-of-flight (TOF) with point spread function (PSF)

Rogasch, J.; Suleiman, S.; Hofheinz, F.; Bluemel, S.; Lukas, M.; et al. (7 authors)


Olfactory dysfunction correlates with putaminal dopamine turnover in early de novo Parkinson’s disease

Löhle, M.; Wolz, M.; Beuthien-Baumann, B.; Oehme, L.; van den Hoff, J.; et al. (8 authors)


Individual patient data meta-analysis of FMISO and FAZA hypoxia PET scans from head and neck cancer patients undergoing definitive radio-chemotherapy

Zschaeck, S.; Löck, S.; Hofheinz, F.; Zips, D.; Mortensen, L.; et al. (17 authors)


Dose dependent cerebellar atrophy in glioma patients after radio(chemo)therapy

Raschke, F.; Seidlitz, A.; Wesemann, T.; Löck, S.; Jentsch, C.; et al. (14 authors)


The sigma-1 receptor: potential role in the modulation of cellular radiation sensitivity

Belter, B.; Deuther-Conrad, W.; Hofheinz, F.; Bachmann, M.; Brust, P.; et al. (6 authors)


Validation of an independent prognostic value of the asphericity of F18-fluorodeoxyglucose (FDG) uptake in non-small cell lung cancer (NSCLC) patients undergoing treatment in curative intent

Rogasch, J.; Furth, C.; Chibolela, C.; Hofheinz, F.; Ochsenreither, S.; et al. (11 authors)


2019

Correlation between FMISO-PET based hypoxia in the primary tumour and in lymph node metastases in locally advanced HNSCC patients

Bandurska-Luque, A.; Löck, S.; Haase, R.; Richter, C.; Zöphel, K.; et al. (14 authors)


Confirmation of the prognostic value of pretherapeutic tumor SUR and MTV in patients with esophageal squamous cell carcinoma

Hofheinz, F.; Li, Y.; Steffen, I.; Lin, Q.; Lili, C.; et al. (8 authors)


Comparison of Static and Dynamic 18F-FDG PET/CT for Quantification of Pulmonary Inflammation in Acute Lung Injury

Braune, A.; Hofheinz, F.; Bluth, T.; Kiss, T.; Wittenstein, J.; et al. (8 authors)


Biomaterials in repairing rat femoral defects: in vivo insights from small animal positron emission tomography/computed tomography (PET/CT) studies

Neuber, C.; Schulze, S.; Förster, Y.; Hofheinz, F.; Wodke, J.; et al. (11 authors)

  • Open Access Logo Clinical Hemorheology and Microcirculation 73(2019), 177-194
    DOI: 10.3233/CH-199208

The association of intra-therapeutic heterogeneity of somatostatin receptor expression with morphological treatment response in patients undergoing PRRT with [177Lu]-DOTATATE

Wetz, C.; Genseke, P.; Apostolova, I.; Furth, C.; Ghazzawi, S.; et al. (11 authors)


Interobserver variability of image-derived arterial blood SUV in whole-body FDG PET

Hofheinz, F.; Maus, J.; Zschaeck, S.; Rogasch, J.; Schramm, G.; et al. (9 authors)


Time efficient scatter correction for time-of-flight PET: the immediate scatter approximation

Nikulin, P.; Maus, J.; Hofheinz, F.; Lougovski, A.; van den Hoff, J.


FDG-PET/MRI in patients with pelvic recurrence of rectal cancer: first clinical experiences

Plodeck, V.; Rahbari, N.; Weitz, J.; Radosa, C.; Laniado, M.; et al. (11 authors)


Prognostic value of SUR in patients with trimodality treatment of locally advanced esophageal carcinoma

Bütof, R.; Hofheinz, F.; Zöphel, K.; Schmollack, J.; Jentsch, C.; et al. (9 authors)


2018

Pretherapeutic FDG–PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin’s lymphoma

Rogasch, J.; Hundsdoerfer, P.; Hofheinz, F.; Wedel, F.; Schatka, I.; et al. (7 authors)


In vivo confirmation of altered hepatic glucose metabolism in patients with liver fibrosis/cirrhosis by 18F-FDG PET/CT

Verloh, N.; Einspieler, I.; Utpatel, K.; Menhart, K.; Brunner, S.; et al. (12 authors)


Monitoring scanner calibration using the image derived arterial blood SUV in whole-body FDG-PET

Maus, J.; Hofheinz, F.; Apostolova, I.; Kreissl, M. C.; Kotzerke, J.; et al. (6 authors)


Increased evidence for the prognostic value of late-treatment FDG-PET uptake in non-tumor affected oesophagus in irradiated patients with oesophageal carcinomas

Li, Y.; Hofheinz, F.; Furth, C.; Lili, C.; Hua, W.; et al. (7 authors)


Effects of systematic partial volume errors on the computation of mean gray matter cerebral blood flow with Arterial Spin Labeling MRI

Petr, J.; Mutsaerts, H. J. M. M.; de Vita, E.; Steketee, R. M. E.; Smits, M.; et al. (9 authors)


Overexpression of receptor tyrosine kinase EphB4 triggers tumor growth and hypoxia in A375 melanoma xenografts: insights from multitracer small animal imaging experiments

Neuber, C.; Belter, B.; Meister, S.; Hofheinz, F.; Bergmann, R.; et al. (7 authors)


Photon vs. proton radiochemotherapy: effects on brain tissue volume and perfusion

Petr, J.; Platzek, I.; Hofheinz, F.; Mutsaerts, H.; Asllani, I.; et al. (16 authors)


2017

Quantification: there is more to worry about than good scanner hardware and reliable calibration

Kotzerke, J.; van den Hoff, J.

  • European Journal of Nuclear Medicine and Molecular Imaging 44(2017)12, 1955-1957
    DOI: 10.1007/s00259-017-3808-z
    ISSN: 1619-7089

Nitric oxide-releasing selective cyclooxygenase-2 inhibitors as promising radiosensitizers in melanoma cells in vitro

Bechmann, N.; Hauser, S.; Hofheinz, F.; Kniess, T.; Pietzsch, J.

  • Open Access Logo Annals of Radiation Therapy and Oncology 1(2017)2, 1010

Potential of asphericity as a novel diagnostic parameter in the evaluation of patients with Ga-68-PSMA-HBED-CC PET-positive prostate cancer lesions

Meissner, S.; Janssen, J.; Prasad, V.; Brenner, W.; Diederichs, G.; et al. (8 authors)


Individualized risk assessment in neuroblastoma: does the tumoral metabolic activity on 123I-MIBG SPECT predict the outcome?

Rogasch, J.; Hundsdoerfer, P.; Furth, C.; Wedel, F.; Hofheinz, F.; et al. (11 authors)


Increased FDG uptake on late-treatment PET in non-tumour-affected oesophagus is prognostic for pathological complete response and disease recurrence in patients undergoing neoadjuvant radiochemotherapy

Zschaeck, S.; Hofheinz, F.; Zöphel, K.; Bütof, R.; Jentsch, C.; et al. (12 authors)


Test-retest variability of lesion SUV and lesion SUR in 18F-FDG PET: an analysis of data from two prospective multicenter trials

Hofheinz, F.; Apostolova, I.; Oehme, L.; Kotzerke, J.; van den Hoff, J.


FDG PET/MR in initial staging of sarcoma: Initial experience and comparison with conventional imaging

Platzek, I.; Beuthien-Baumann, B.; Schramm, G.; Maus, J.; Laniado, M.; et al. (8 authors)


Predictive Value of Asphericity in Pretherapeutic [111In]DTPA-Octreotide SPECT/CT for Response to Peptide Receptor Radionuclide Therapy with [177Lu]DOTATATE

Wetz, C.; Apostolova, I.; Steffen, I. G.; Hofheinz, F.; Furth, C.; et al. (10 authors)


2016

The asphericity of the metabolic tumour volume in NSCLC: correlation with histopathology and molecular markers

Apostolova, I.; Ego, K.; Steffen, I. G.; Buchert, R.; Wertzel, H.; et al. (14 authors)


Comparative evaluation of SUV, tumor-to-blood standard uptake ratio (SUR), and dual time point measurements for assessment of the metabolic uptake rate in FDG PET

Hofheinz, F.; van den Hoff, J.; Steffen, I. G.; Lougovski, A.; Ego, K.; et al. (7 authors)


Putaminal dopamine turnover in de novo Parkinson disease predicts later motor complications

Loehle, M.; Mende, J.; Wolz, M.; Beuthien-Baumann, B.; Oehme, L.; et al. (9 authors)


An investigation of the relation between tumor-to-liver ratio (TLR) and tumor-to-blood standard uptake ratio (SUR) in oncological FDG PET.

Hofheinz, F.; Bütof, R.; Apostolova, I.; Zöphel, K.; Steffen, I. G.; et al. (9 authors)


Early and late effects of radiochemotherapy on cerebral blood flow in glioblastoma patients measured with non-invasive perfusion MRI

Petr, J.; Platzek, I.; Seidlitz, A.; Mutsaerts, H. J. M. M.; Hofheinz, F.; et al. (10 authors)


2015

Positron emission tomography 2013 in Germany: Results of the query and current status

Kotzerke, J.; Oehme, L.; Grosse, J.; Hellwig, D.; Bartenstein, P.; et al. (23 authors)


Increased evidence for the prognostic value of primary tumor asphericity in pretherapeutic FDG PET for risk stratification in patients with head and neck cancer.

Hofheinz, F.; Lougovski, A.; Zöphel, K.; Hentschel, M.; Steffen, I. G.; et al. (12 authors)


Probleme der SUV-Quantifizierung in der Positronenemissionstomografie und mögliche Lösungswege/Problems of SUV Quantification in Positron Emission Tomography and Possible Solutions

van den Hoff, J.; Hofheinz, F.


Prognostic Value of Pretherapeutic Tumor-to-Blood Standardized Uptake Ratio in Patients with Esophageal Carcinoma

Bütof, R.; Hofheinz, F.; Zöphel, K.; Stadelmann, T.; Schmollack, J.; et al. (10 authors)


Correction of quantification errors in pelvic and spinal lesions caused by ignoring higher photon attenuation of bone in [18F]NaF PET/MR

Schramm, G.; Maus, J.; Hofheinz, F.; Petr, J.; Lougovski, A.; et al. (9 authors)


Evaluation of in vivo quantification accuracy of the Ingenuity-TF PET/MR

Maus, J.; Schramm, G.; Hofheinz, F.; Oehme, L.; Lougovski, A.; et al. (11 authors)


18F-FDG PET/MRI for therapy response assessment in sarcoma: Comparison of PET and MR imaging results

Schuler, M. K.; Platzek, I.; Beuthien-Baumann, B.; Fenchel, M.; Ehninger, G. E.; et al. (6 authors)


Repeatability of tumor SUV quantification: the role of variable blood SUV

van den Hoff, J.; Hofheinz, F.


On the relation between Kaiser-Bessel blob and tube of response based modelling of the system matrix in iterative PET image reconstruction

Lougovski, A.; Hofheinz, F.; Maus, J.; Schramm, G.; van den Hoff, J.


Combined PET/MR: The Real Work Has Just Started. Summary Report of the Third International Workshop on PET/MR Imaging; February 17-21, 2014, Tubingen, Germany

Bailey, D. L.; Antoch, G.; Bartenstein, P.; Barthel, H.; Beer, A. J.; et al. (27 authors)


The association of tumor-to-background ratios and SUVmax deviations related to point spread function and time-of-flight F18-FDG-PET/CT reconstruction in colorectal liver metastases

Rogasch, J. M. M.; Steffen, I. G.; Hofheinz, F.; Großer, O. S.; Furth, C.; et al. (10 authors)


2014

Quantitative assessment of the asphericity of pretherapeutic FDG uptake as an independent predictor of outcome in NSCLC.

Apostolova, I.; Rogasch, J.; Buchert, R.; Wertzel, H.; Achenbach, H. J.; et al. (13 authors)


The influence of different signal-to-background ratios on spatial resolution and F18-FDG-PET quantification using point spread function and time-of-flight reconstruction

Rogasch, J. M. M.; Hofheinz, F.; Lougovski, A.; Furth, C.; Ruf, J.; et al. (11 authors)


FDG PET/MR for the Assessment of Lymph Node Involvement in Lymphoma: Initial Results and Role of Diffusion-Weighted MR

Platzek, I.; Beuthien-Baumann, B.; Ordemann, R.; Maus, J.; Schramm, G.; et al. (9 authors)


Asphericity of pretherapeutic tumour FDG uptake provides independent prognostic value in head-and-neck cancer

Apostolova, I.; Steffen, I. G.; Wedel, F.; Lougovski, A.; Marnitz, S.; et al. (10 authors)


Periacetabular bone metabolism following hip revision surgery. PET-based evaluation of allograft osteointegration.

Bernstein, P.; Beuthien-Baumann, B.; Kotzerke, J.; Hofheinz, F.; Zessin, J.; et al. (7 authors)


Combined measurement of tumor perfusion and glucose metabolism for improved tumor characterization in advanced cervical carcinoma: A PET/CT pilot study using [15O]water and [18F]fluorodeoxyglucose

Apostolova, I.; Hofheinz, F.; Buchert, R.; Steffen, I. G.; Michel, R.; et al. (11 authors)


Evaluation and automatic correction of metal-implant-induced artifacts in MR-based attenuation correction in whole-body PET/MR imaging

Schramm, G.; Maus, J.; Hofheinz, F.; Petr, J.; Lougovski, A.; et al. (8 authors)


FDG PET/MR for lymph node staging in head and neck cancer

Platzek, I.; Beuthien-Baumann, B.; Schneider, M.; Gudziol, V.; Kitzler, H. H.; et al. (11 authors)


Correction of scan time dependence of standard uptake values in oncological PET

van den Hoff, J.; Lougovski, A.; Schramm, G.; Maus, J.; Oehme, L.; et al. (9 authors)


Combined PET/MR: Where Are We Now? Summary Report of the Second International Workshop on PET/MR Imaging April 8–12, 2013, Tubingen, Germany

Bailey, D. L.; Barthel, H.; Beuthien-Baumann, B.; Beyer, T.; Bisdas, S.; et al. (29 authors)


Evaluation of PET quantification accuracy in vivo - Comparison of measured FDG concentration in the bladder with urine samples / In-vivo-Evaluation der Quantifizierungsgenauigkeit der PET - Vergleich der gemessenen FDG-Konzentration in der Blase mit Urinproben

Maus, J.; Hofheinz, F.; Schramm, G.; Oehme, L.; Beuthien-Baumann, B.; et al. (10 authors)


A volume of intersection approach for on-the-fly system matrix calculation in 3D PET image reconstruction

Lougovski, A.; Hofheinz, F.; Langner, J.; Schramm, G.; Will, E.; et al. (6 authors)


Development of 18F-labeled radiotracers for neuroreceptor imaging with positron emission tomography

Brust, P.; van den Hoff, J.; Steinbach, J.


Performance Evaluation of Stationary and Semi-Stationary Acquisition with a Non-Stationary Small Animal Multi-Pinhole SPECT System

Lange, C.; Apostolova, I.; Lukas, M.; Huang, K. P.; Hofheinz, F.; et al. (8 authors)


Modeling Magnetization Transfer Effects of Q2TIPS Bolus Saturation in Multi-TI Pulsed Arterial Spin Labeling

Petr, J.; Schramm, G.; Hofheinz, F.; Langner, J.; van den Hoff, J.

  • Magnetic Resonance in Medicine 72(2014), 1007-1014
    Online First (2013) DOI: 10.1002/mrm.25011

2013

Assessment of the diagnostic performance of 18F-FDG-PET/CT for detection and characterization of solid renal malignancies.

Nakhoda, Z.; Torigian, D. A.; Saboury, B.; Hofheinz, F.; Alavi, A.

  • Open Access Logo Hellenic Journal of Nuclear Medicine 16(2013), 19-24

PET/MRI Imaging in High-Risk Sarcoma: First Findings and Solving Clinical Problems

Schuler, M. K.; Richter, S.; Beuthien-Baumann, B.; Platzek, I.; Kotzerke, J.; et al. (8 authors)


Pulmonary Blood Flow Increases in Damaged Regions Directly after Acid Aspiration in Rats

Richter, T.; Bergmann, R.; Knels, L.; Hofheinz, F.; Kasper, M.; et al. (9 authors)


Influence of rigid coregistration of PET and CT data on metabolic volumetry: a user's perspective

Steffen, I. G.; Hofheinz, F.; Rogasch, J. M. M.; Furth, C.; Amthauer, H.; et al. (6 authors)


Comment on: "Transconvolution and the virtual positron emission tomograph: A new method for cross calibration in quantitative PET/CT imaging"

Hofheinz, F.; van den Hoff, J.


Influence and Compensation of Truncation Artifacts in MR-Based Attenuation Correction in PET/MR

Schramm, G.; Langner, J.; Hofheinz, F.; Petr, J.; Lougovski, A.; et al. (8 authors)


An automatic method for accurate volume delineation of heterogeneous tumors in PET

Hofheinz, F.; Langner, J.; Petr, J.; Beuthien-Baumann, B.; Steinbach, J.; et al. (7 authors)


Effects of dopaminergic treatment on striatal dopamine turnover in de novo Parkinson disease

Storch, A.; Wolz, M.; Beuthien-Baumann, B.; Loehle, M.; Herting, B.; et al. (12 authors)


The PET-derived tumor-to-blood standard uptake ratio (SUR) is superior to tumor SUV as a surrogate parameter of the metabolic rate of FDG

van den Hoff, J.; Oehme, L.; Schramm, G.; Langner, J.; Lougovski, A.; et al. (8 authors)


Dual time point based quantification of metabolic uptake rates in 18F-FDG PET

van den Hoff, J.; Hofheinz, F.; Oehme, L.; Schramm, G.; Langner, J.; et al. (8 authors)


Comments on “Comparative Study With New Accuracy Metrics for Target Volume Contouring in PET Image Guided Radiation Therapy”

van den Hoff, J.; Hofheinz, F.

  • IEEE Transactions on Medical Imaging 32(2013), 1146-1148
    Online First (2012) DOI: 10.1109/TMI.2012.2233209
    ISSN: 0278-0062

PET/MR for therapy response evaluation in malignant lymphoma: initial experience

Platzek, I.; Beuthien-Baumann, B.; Langner, J.; Popp, M.; Schramm, G.; et al. (9 authors)

  • Open Access Logo Magnetic Resonance Materials in Physics, Biology and Medicine 26(2013)1, 49-55
    Online First (2012) DOI: 10.1007/s10334-012-0342-7

PET/MR in head and neck cancer: initial experience

Platzek, I.; Beuthien-Baumann, B.; Schneider, M.; Gudziol, V.; Langner, J.; et al. (9 authors)

  • Open Access Logo European Journal of Nuclear Medicine and Molecular Imaging 40(2013), 6-11
    Online First (2012) DOI: 10.1007/s00259-012-2248-z

Partial volume correction in arterial spin labeling using a Look-Locker sequence

Petr, J.; Schramm, G.; Hofheinz, F.; Langner, J.; Steinbach, J.; et al. (6 authors)

  • Magnetic Resonance in Medicine 70(2013), 1535-1543
    Online First (2012) DOI: 10.1002/mrm.24601

Quantitative accuracy of attenuation correction in the Philips Ingenuity TF whole-body PET/MR system A direct comparison with transmission-based attenuation correction

Schramm, G.; Langner, J.; Hofheinz, F.; Petr, J.; Beuthien-Baumann, B.; et al. (9 authors)

  • Open Access Logo Magnetic Resonance Materials in Physics, Biology and Medicine 25(2013)1, 115-126
    Online First (2012) DOI: 10.1007/s10334-012-0328-5

Use of targeted therapy for refractory ALK-positive anaplastic large cell lymphoma as a bridging strategy prior to allogeneic transplantation

Ordemann, R.; Stöhlmacher, J.; Beuthien-Baumann, B.; Platzek, I.; van den Hoff, J.; et al. (11 authors)


Years: 2023 2022 2021 2020 2019 2018 2017 2016 2015


Pages: [All] [1.] [2.]